The price target of RPAY has been increased from a previous price target of $25 to a relatively new one at $26- by Morgan Stanley. The price target was then published in a research report last Tuesday, where the company had a rating of equal weight. The increase in the price target as fixed by the brokerage indicates an annual growth of 14.89%.
The Quarterly Estimates Of RPAY
There have been quite a few research equities that have commented on the stocks of RPAY. Wells Fargo & Company has already increased the price rating of the company from equal weight to overweight, along with a price target of $29 set on the company. Zacks Investment Research has also reduced the price rating of the company from hold to sell in a 9th January research report.
One of the investment analysts working on the stocks of RPAY has already given it a rating of sell, while another analyst gave it a rating of hold. Ten different investment analysts gave the company a rating of buy. Currently, the company has a buy rating with a $27.08 price target.
The stocks of RPAY traded on Tuesday at $22.63. The moving average price of the company over 50 days is $24.18, while the moving average price of the company over 200 days is $24.40. The year low of the company is $10.69, while the year high has been set at $28.42. The current ratio of the company is at 3.61, while it has a 0.45 debt-to-equity ratio. RPAY currently has a market cap of around $1.79 billion, with a 0.78 beta, and a -66.56 PE ratio.
The company had previously updated its quarterly report on the 28th of February. The EPS reported by the company was $0.17, which was more than the analyst estimate of around $0.11. The company also had a 3.75% return on equity, along with a -12.06% net margin. The revenue generated by the company over the quarter was $41.44 million, which was more than the consensus estimate of $38.72 million.
